has anyone gotten cancer from semaglutide For years, researchers have known that obesity is associated with an increased risk of developing and dying several cancers, including breast cancer. At ASCO 2026, new studies examining GLP-1 receptor agonists Do GLP-1 drugs like Ozempic

The most common adverse effects associated with GLP-1 medications are gastrointestinal in nature, including nausea, vomiting, diarrhea, constipation, and abdominal discomfort

Full therapeutic benefit typically develops over 612 weeks of consistent use

Be sure to include the brand name, dose, route, frequency, and indication of each GLP-1 agonist medication, if applicable

Formulated for once-weekly administration via a specialized pre-filled pen to ensure consistent dosing and patient compliance

The GLP-1 drug market has been dominated by Novo Nordisk (NVO) and Eli Lilly (LLY), whose products Ozempic and Monjaro are widely used for diabetes and weight management